-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $88

Benzinga·06/15/2026 13:12:04
Listen to the news
Piper Sandler analyst Matt O'Brien maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $75 to $88.